Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- A. Osama Gaber, MD
The Methodist Hospital Research Institute
Study Director - Arthur Matas, MD
University of Minnesota
Study Director - Daniel Abramowicz, MD, PhD
Erasme University Hospital
Study Director - Mark Pescovitz, MD
Indiana University
Study Director - Philip Belitsky, MD
No Affiliation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Isotechnika Investigational Site
Edmonton, Alberta, Canada
- Isotechnika Investigational Site
London, Ontario, Canada
- Isotechnika Investigational Site
Toronto, Ontario, Canada
- Isotechnika Investigational Site
Montreal, Quebec, Canada
- Isotechnika Investigational Site
Saskatoon, Saskatchewan, Canada
- Isotechnika Investigational Site
Birmingham, Alabama, United States
- Isotechnika Investigational Site
Los Angeles, California, United States
- Isotechnika Investigational Site
Los Angeles, California, United States
- Isotechnika Investigational Site
Los Angeles, California, United States
- Isotechnika Investigational Site
Orange, California, United States
- Isotechnika Investigational Site
Palo Alto, California, United States
- Isotechnika Investigational Site
San Diego, California, United States
- Isotechnika Investigational Site
San Francisco, California, United States
- Isotechnika Investigational Site
Denver, Colorado, United States
- Isotechnika Investigational Site
Gainesville, Florida, United States
- Isotechnika Investigational Site
Tampa, Florida, United States
- Isotechnika Investigational Site
Chicago, Illinois, United States
- Isotechnika Investigational Site
Chicago, Illinois, United States
- Isotechnika Investigational Site
Lexington, Kentucky, United States
- Isotechnika Investigational Site
New Orleans, Louisiana, United States
- Isotechnika Investigational Site
New Orleans, Louisiana, United States
- Isotechnika Investigational Site
Baltimore, Maryland, United States
- Isotechnika Investigational Site
Boston, Massachusetts, United States
- Isotechnika Investigational Site
Ann Arbor, Michigan, United States
- Isotechnika Investigational Site
Detroit, Michigan, United States
- Isotechnika Investigational Site
Rochester, Minnesota, United States
- Isotechnika Investigational Site
Livingston, New Jersey, United States
- Isotechnika Investigational Site
Buffalo, New York, United States
- Isotechnika Investigational Site
Hawthorne, New York, United States
- Isotechnika Investigational Site
New York, New York, United States
- Isotechnika Investigational Site
Rochester, New York, United States
- Isotechnika Investigational Site
Durham, North Carolina, United States
- Isotechnika Investigational Site
Winston-Salem, North Carolina, United States
- Isotechnika Investigational Site
Cincinnati, Ohio, United States
- Isotechnika Investigational Site
Cincinnati, Ohio, United States
- Isotechnika Investigational Site
Portland, Oregon, United States
- Isotechnika Investigational Site
Portland, Oregon, United States
- Isotechnika Investigational Site
Portland, Oregon, United States
- Isotechnika Investigational Site
Philadelphia, Pennsylvania, United States
- Isotechnika Investigational Site
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jul 2009
- Last update posted
- 12 Feb 2013
- Registered enrollment
- 334
- Registry id
- NCT00270634
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.